Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics One of H. pylori’s defining characteristics is right there in ...

Researchers have found in a new study that higher-than-standard doses of antibiotics or bismuth in quadruple regimens for ...

Helicobacter pylori (H. pylori) is a common type of bacteria that infects the stomach lining and can lead to various gastrointestinal diseases such as gastritis, stomach ulcers, and cancer. The ...

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...

1. Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2016;3(2):183-191. doi:10.1016/j.jcmgh.2016.12.001 2 ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Is the game up for Helicobactor pylori? Researchers have identified the molecular mechanism that the bacterium's best-known adhesion protein uses to attach to stomach sugars and evade the body's ...

Csd5 is unlikely to be a lone player in the orchestration of H. pylori cell shape. As such, the authors looked for Csd5 protein interaction partners using immunoprecipitation (IP) and mass ...

The American Journal of Managed Care® (AJMC®): What treatment options or regimens for Helicobacter pylori exist that are not reflected in the 2017 American College of Gastroenterology (ACG) guidelines ...